Mobile Cardiac Telemetry Market Size, Share, Growth Analysis, By Application(lead based and patch based), By Type(hospitals, cardiac centres and others), By Region - Industry Forecast 2024-2031

Mobile Cardiac Telemetry Market size was valued at USD 833.8 million in 2019 and is poised to grow from USD 900 million in 2023 to USD 2300 million by 2031, growing at a CAGR of 12.1% in the forecast period (2024-2031).

MCT or MCOT stands for mobile cardiac telemetry systems, and it is the most popular technology in the ambulatory cardiac monitoring sector. The device provides advanced real-time analysis technology and reduces the cost of electrocardiographic diagnosis for outpatients. This is a small portable device that can be taken anywhere. It provides benefits to both the patient and the physician, potentially leading to more efficient care. The rising prevalence of cardiovascular diseases, the benefits of monitoring patients with mobile cardiac telemetry (MCT), and the growing geriatric population are driving the growth of the Mobile Cardiac Telemetry Systems in the healthcare market. Cardiovascular diseases (CVDs) are heart and blood vessel disorders that include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and others. Tobacco use, an unhealthy diet, and physical inactivity, which increases the risk of heart attacks and strokes, are some of the major factors that contribute to death and difficulties. CVDs are the leading cause of death worldwide, affecting more people than any other disease. The mobile cardiac telemetry (MCT) system consists of a small sensor and monitor that patients wear on a daily basis. Whenever a cardiac event occurs, MCT instantly transmits the data to a centre for analysis and response, which then sends a report to the patient's physician along with graphs and trends for diagnosis and therapy management.

US Mobile Cardiac Telemetry Market is poised to grow at a sustainable CAGR for the next forecast year.